After surgery, patients who undergo transcatheter aortic valve implantation (TAVI) are at risk of developing cardiac arrhythmias such as heart blocks and atrial fibrillation. Current practice is to monitor TAVI patients in hospital for 2-8 days post procedure using scarce and expensive hospital telemetry beds. This study will use a new monitoring service called mobile Cardiac Arrhythmia Diagnostics Service (m-CARDS) to risk stratify patient pre-TAVI and provide an added layer of monitoring that would support earlier discharge of suitably identified patients 24-hours post TAVI. The study will assess whether this strategy will significantly reduce the pressure on hospital resources while improving patient outcomes and experience.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Feasibility: Recruitment rate
Timeframe: End of study (Approximately Month 24)
Feasibility: Participant adherence to monitoring pre-TAVI
Timeframe: End of pre-TAVI monitoring period (Day 14)
Feasibility: Participant adherence to monitoring post-TAVI
Timeframe: End of post-TAVI monitoring period (approximately Month 2 dependent on scheduling of TAVI procedure)
Feasibility: Requirement for PPM pre-TAVI
Timeframe: End of pre-TAVI monitoring period (Day 14)
Feasibility: Participant adherence to post-TAVI monitoring protocol
Timeframe: End of post-TAVI monitoring period (approximately Month 2)
Feasibility: Timeliness of medical assessment of participants with "serious" arrhythmia identified on monitor pre-TAVI
Timeframe: End of pre-TAVI monitoring period (Day 14)
Feasibility: Timeliness of medical assessment of participants with "serious" arrhythmia identified on monitor post-TAVI
Timeframe: End of post-TAVI monitoring period (approximately Month 2)
Patient Experience Questionnaire
Timeframe: 30-day follow-up
Clinical Team Experience Questionnaire
Timeframe: 30-day follow-up
Number of participant or clinical team activations based on monitor findings pre-TAVI
Timeframe: End of pre-TAVI monitoring period (Day 14)
Number of participant or clinical team activations based on monitor findings post-TAVI
Timeframe: End of post-TAVI monitoring period (approximately Month 2)
Time from identification of findings on remote monitor to clinical team activation for pre-TAVI findings.
Timeframe: End of pre-TAVI monitoring period (Day 14)
Time from identification of findings on remote monitor to clinical team activation for post-TAVI findings.
Timeframe: End of post-TAVI monitoring period (approximately Month 2)